Articles
A photographer’s perspective on DME imaging
While some practices rely solely on OCT, others continue to depend on fluorescein angiography.
By Bill Kekevian, Senior
Conjunctival tumor watch
The appearance of these tumors can be deceptively harmless; some simulate other conditions. Most are benign, but even those require scrutiny.
By Carol Shields, MD
Diabetes, the eye, and the treatment of both
Diabetic eye disease creates a major challenge in the development of vision-sustaining drugs.
By Karen Appold, contributing writer
DME drugs multiply
Two new steroid implants offer two-pronged attack, durability.
By Veeral S. Sheth, MD, MBA, FACS
Interested in closing the ‘treatment loop’?
Merely having a dispensary isn’t enough — first you need to appreciate business terms such as ‘capture rate.’
By Stuart Michaelson, Contributing
Maybe downsizing is not the answer
Industry experts say to thoroughly evaluate and consider all alternatives before scaling back your practice.
By Zack Tertel, managing editor
Quick Hits
By By ReN
Return on experience – place a value on ROE
While it’s not the primary goal, a quality patient experience can lead to a positive ROI.
By Vance Thompson, MD
SPOTLIGHT ON TECHNOLOGY & TECHNIQUE
PSF Integra offers a target system aimed at precision
By Zack Tertel, managing editor
Telemedicine brings teamwork to battling DR
The new paradigm forges a logical partnership between ophthalmology and primary care.
By Seema Garg, MD, PhD
THE ENLIGHTENED OFFICE
Patient surveys give us insights into our patients’ minds
By Cynthia Matossian, MD, FACS
Viewpoint
Our Policy: The Door Is Open
Which DME patients are right for surgery?
Despite an expanding formulary to treat diabetic macular edema, some patients’ singular situations call for a surgical approach.
By Apurva Patel, MD